Hyperion Capital Advisors LP Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Hyperion Capital Advisors LP cut its position in UnitedHealth Group Incorporated (NYSE:UNH) by 3.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 25,627 shares of the healthcare conglomerate’s stock after selling 781 shares during the quarter. UnitedHealth Group accounts for about 7.0% of Hyperion Capital Advisors LP’s portfolio, making the stock its 5th largest holding. Hyperion Capital Advisors LP’s holdings in UnitedHealth Group were worth $14,984,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in UNH. Tealwood Asset Management Inc. bought a new position in UnitedHealth Group in the third quarter valued at about $2,905,000. Asset Planning Services Inc. LA ADV grew its holdings in shares of UnitedHealth Group by 1.2% during the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock valued at $7,288,000 after purchasing an additional 150 shares during the last quarter. Sequoia Financial Advisors LLC grew its stake in shares of UnitedHealth Group by 13.7% during the third quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock worth $14,603,000 after buying an additional 3,006 shares during the last quarter. Americana Partners LLC grew its stake in shares of UnitedHealth Group by 10.8% during the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock worth $11,914,000 after buying an additional 1,984 shares during the last quarter. Finally, Meridian Wealth Management LLC grew its stake in shares of UnitedHealth Group by 13.1% during the third quarter. Meridian Wealth Management LLC now owns 31,162 shares of the healthcare conglomerate’s stock worth $18,220,000 after buying an additional 3,603 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Up 0.3 %

UNH stock opened at $608.38 on Thursday. The company has a market capitalization of $559.88 billion, a price-to-earnings ratio of 39.63, a PEG ratio of 1.78 and a beta of 0.58. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a fifty day moving average of $584.09 and a 200-day moving average of $555.02.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the firm posted $6.56 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be paid a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.38%. UnitedHealth Group’s payout ratio is 54.72%.

Analysts Set New Price Targets

A number of analysts have weighed in on UNH shares. Cantor Fitzgerald boosted their target price on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 16th. UBS Group cut their price target on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, November 20th. Finally, Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $618.26.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.